Details of the Drug

General Information of Drug (ID: DME7K0P)

• Drug Name: Oportuzumab monatox

Indication

Disease Entry	ICD 11	Status	REF
Bladder cancer	2C94	Phase 3	[1]
Head and neck cancer	2D42	Phase 2	[1]

• ATC Code:
  L01FX16: Oportuzumab monatox
  L01FX: Other monoclonal antibodies and antibody drug conjugates
  L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
  L01: ANTINEOPLASTIC AGENTS
  L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
• Cross-matching ID:
  UNII: 945CY7ZMI2
  DrugBank ID: DB05319
  TTD ID: D0OF1R
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)